Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO - Kanpitcha Jiramitmongkon; Pichayanoot Rotkrua; Paisan Khanchaitit; Jiraporn Arunpanichlert; Boonchoy Soontornworajit (PLoS ONE, 2025)